Deborah H. Telman - 25 Jul 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
25 Jul 2024
Net transactions value
-$223,180
Form type
4
Filing time
26 Jul 2024, 17:28:51 UTC
Previous filing
11 Jun 2024
Next filing
11 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Tax liability $223,180 -2,917 -20% $76.51 11,631 25 Jul 2024 Direct
transaction GILD Common Stock Options Exercise +514 +4.4% 12,145 25 Jul 2024 Direct F1
transaction GILD Common Stock Options Exercise +8,230 +68% 20,375 25 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -514 -1.3% 38,416 25 Jul 2024 Common Stock 514 Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -8,230 -21% 30,186 25 Jul 2024 Common Stock 8,230 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested.